Mark Edelstein
Impact in
-
- Acute Myeloid Leukemia Research
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 4
- DNA Repair Mechanisms 3
- Biochemical and Molecular Research 3
- Oncology 8
- Cancer Cells and Metastasis 3
- Co-authors
- Teresa J. Vietti (3 shared papers)Fred Valeriote (7 shared papers)Frederick A. Valeriote (4 shared papers)L. M. van Putten (7 shared papers)Heinz H. Fiebig (1 shared paper)Thomas H. Corbett (2 shared papers)Laurence H. Baker (1 shared paper)Michael Bischoff (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)Cancer Investigation (2 papers)Cancer treatment and research (1 paper)Biochemical Pharmacology (1 paper)Blood (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Mark Edelstein
27 papers receiving 307 citations
Peers
Comparison fields: 5 of 57
- Hematology 57
- Cancer Research 66
- Oncology 103
- Genetics 36
- Pathology and Forensic Medicine 39
Countries citing papers authored by Mark Edelstein
This map shows the geographic impact of Mark Edelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Edelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Edelstein more than expected).
Fields of papers citing papers by Mark Edelstein
This network shows the impact of papers produced by Mark Edelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Edelstein. The network helps show where Mark Edelstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Edelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 48 | |
| 2 | Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin. | 1974 | 42 |
| 3 | 1983 | 39 | |
| 4 | The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate. | 1975 | 32 |
| 5 | 1997 | 26 | |
| 6 | 1984 | 25 | |
| 7 | In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells. | 1989 | 24 |
| 8 | 1996 | 22 | |
| 9 | 1977 | 22 | |
| 10 | 1983 | 9 | |
| 11 | 1978 | 8 | |
| 12 | Combined effect of cytosine arabinoside and thiopurines. | 1976 | 6 |
| 13 | 1985 | 5 | |
| 14 | 1989 | 5 | |
| 15 | 1986 | 5 | |
| 16 | 1986 | 5 | |
| 17 | 1983 | 4 | |
| 18 | Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents. | 1984 | 4 |
| 19 | Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice. | 1988 | 4 |
| 20 | 1990 | 3 |
About Mark Edelstein
Mark Edelstein is a scholar working on Molecular Biology, Oncology, Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 28 papers that have together received 351 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Cells and Metastasis (3 papers), Effects of Radiation Exposure (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Hematology (57 citations), Cancer Research (66 citations), Oncology (103 citations), Genetics (36 citations) and Pathology and Forensic Medicine (39 citations). Mark Edelstein has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Teresa J. Vietti, Fred Valeriote, Frederick A. Valeriote, L. M. van Putten, Heinz H. Fiebig, Thomas H. Corbett, Laurence H. Baker, Michael Bischoff, P. Lelieveld and Arun K. Rishi. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer Investigation, Cancer treatment and research, Biochemical Pharmacology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.